Perspective Therapeutics, Inc. — Director's Dealing 2024

Dec 4, 2024

SEC Form 4/A — Form 4/A

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-11-25

Reporting Person: Williamson Robert F III (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48645	Direct
Common Stock	366	Indirect

Footnotes

F1: Beneficial ownership was reported to be 430,058 and should have been reported as 48,645.

F2: Beneficial ownership was reported to be 3,663 and should have been reported as 366.